Nausea and Vomiting in Pregnancy
📧 Sign up to get email alerts when something new happens for Nausea and Vomiting in Pregnancy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Guided Imagery for Nausea and Well-Being in Pregnant Women [NA]
A completed clinical trial from Inonu University evaluated guided imagery as an intervention to alleviate nausea and improve well-being in p…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Virtual Reality (VR) Based Relaxation for Nausea and Comfort in Pregnancy [NA]
Clinical trial update noting ongoing enrollment for a study testing virtual reality-based relaxation to reduce nausea and enhance comfort in…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting [NA]
Clinical trial update reporting on alternate nostril breathing as an intervention for nausea and vomiting in the first trimester, with recru…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Thumbtack Needle in the Treatment of NVP [NA]
A clinical trial evaluating the Thumbtack Needle therapy for nausea and vomiting in pregnancy (NVP) is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Ottawa Nutritional Guidelines for Nausea and Vomiting [NA]
This completed clinical trial evaluated Ottawa-style nutritional guidelines for managing nausea and vomiting in pregnancy (nausea gravidarum…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-12-11Clinical Trial Update: Endeavor to Stop Nausea/Vomiting Associated With Pregnancy (E-SNAP) [Phase 1, Phase 2]
The Endeavor to Stop Nausea/Vomiting Associated with Pregnancy (E-SNAP) trial, a Phase 1/2 study sponsored by Northwestern University invest…
-
FDA approval · 2023-08-04FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Original Application (Bionpharma Inc.,)
FDA approved an original application for a generic combination of doxylamine succinate and pyridoxine hydrochloride for nausea and vomiting …
-
FDA approval · 2022-10-31FDA Approved: BONJESTA — Supplemental Application (Duchesnay USA, Inc.)
The FDA approved a supplemental application for Bonjesta (doxylamine succinate and pyridoxine hydrochloride) submitted by Duchesnay USA, Inc…
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Effectiveness of Acupuncture and Doxylamine/Pyridoxine for Moderate to Severe Nausea and Vomiting in Pregnancy [Phase 3]
Phase 3 trial updating the effectiveness of acupuncture combined with doxylamine/pyridoxine for moderate to severe nausea and vomiting in pr…
-
FDA approval · 2020-07-06FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan's original application for a generic combination tablet of doxylamine succinate and pyridoxine hydrochloride, used for na…
-
FDA approval · 2020-02-24FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
The FDA approved Endo USA, Inc.'s supplemental application for a delayed-release tablet combining doxylamine succinate and pyridoxine hydroc…
-
FDA approval · 2018-06-18FDA Approved: BONJESTA — Supplemental Application (Duchesnay USA, Inc.)
FDA approved a supplemental application for BONJESTA (doxylamine succinate and pyridoxine hydrochloride) from Duchesnay USA, Inc.
-
FDA approval · 2018-06-18FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Analog Pharma)
FDA approves Analog Pharma's supplemental application for doxylamine succinate and pyridoxine hydrochloride. The product is used for nausea …
-
FDA approval · 2017-12-06FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Original Application (Endo USA, Inc.)
The FDA approved Endo USA, Inc.'s original application for a generic doxylamine succinate and pyridoxine hydrochloride delayed-release table…
-
FDA approval · 2014-11-24FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Analog Pharma)
The FDA approved a supplemental application for doxylamine succinate and pyridoxine hydrochloride (Analog Pharma), a medication used for nau…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Improving Multivitamin Supplementation to Pregnant Women [Phase 4]
Phase 4 trial evaluating improved multivitamin supplementation for pregnant women to address morning sickness, including nausea and vomiting…
-
FDA approval · 2014-07-30FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Analog Pharma)
FDA approved a supplemental application for doxylamine succinate and pyridoxine hydrochloride (Analog Pharma), updating the labeling under N…
-
FDA approval · 2014-01-29FDA Approved: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE — Supplemental Application (Analog Pharma)
The FDA approved a supplemental application for the doxylamine succinate and pyridoxine hydrochloride combination from Analog Pharma.
-
CLINICAL_TRIALS trial_result · 2008-12-31Clinical Trial Update: B6 Treatment for Nausea and Vomiting in Pregnancy [Phase 4]
Phase 4 clinical trial update evaluating pyridoxine (vitamin B6) for nausea and vomiting in early pregnancy.